Infrapatellar

TCT 2025 | LIFE-BTK: Three-Year Results of the Everolimus-Eluting Resorbable Scaffold in Infrapopliteal Lesions in Patients with Critical Limb Ischemia

Patients with chronic limb-threatening ischemia (CLTI) are among the most challenging in endovascular revascularization. While endovascular treatment...

Dr. Omar Tupayachi - 30 October, 2025

Learn More

Coronary disease

LIFE-BTK | Critical Limb Ischemia: Use of Bioresorbable Scaffold in Infrapatellar Lesions (LIFE-BTK)

Advanced stages of peripheral artery disease cause significant limitations in patients, such as critical limb ischemia (CLI),...

solaci - 19 January, 2024

Learn More

Infrapatellar

TCT 2023 The LIFE-BTK Trial

This was a randomized study including 261 patients treated with infrapatellar percutaneous transluminal angioplasty.173 of these patients...

solaci - 30 October, 2023

Learn More

Infrapatellar

BASIL-2: Revascularization of Infra-Popliteal Territory in Patients with Critical Lower Limb Ischemia

Results of infrapopliteal territory revascularization in critical limb ischemia. Compared against the general population, patients suffering from critical...

solaci - 22 June, 2023

Learn More

Femoral

Watch again our Webinar on Lower Limb Angioplasty: LATAM Peripheral Registry

Watch again our Webinar on "Lower Limb Angioplasty: LATAM Peripheral Registry " on our Youtube account. The...

solaci - 14 May, 2021

Learn More

Femoropopliteal

Optimal Medical Treatment Under-used in Vascular Peripheral Disease

Less than half of patients undergoing endovascular revascularization for peripheral artery disease to their lower limbs are...

solaci - 28 January, 2021

Learn More

Antiplatelet

Diabetes and Peripheral Vascular Disease: Old Drugs, New Evidence

This paper, recently published in JAHA, showed that patients with type 2 diabetes mellitus exhibiting lower-limb vascular disease...

solaci - 7 January, 2021

Learn More

Infrapatellar

Drug-Coated Balloons in Critical Ischemia: The Paradigm of Randomized Evidence vs. Logbooks

This research, which included thousands of patients treated for chronic inferior limb ischemia with drug-coated balloons, did...

solaci - 13 October, 2020

Learn More

Infrapatellar

TCT 2025 | LIFE-BTK: Three-Year Results of the Everolimus-Eluting Resorbable Scaffold in Infrapopliteal Lesions in Patients with Critical Limb Ischemia

LIFE-BTK | Critical Limb Ischemia: Use of Bioresorbable Scaffold in Infrapatellar Lesions (LIFE-BTK)

TCT 2023 The LIFE-BTK Trial

BASIL-2: Revascularization of Infra-Popliteal Territory in Patients with Critical Lower Limb Ischemia

Watch again our Webinar on Lower Limb Angioplasty: LATAM Peripheral Registry

Optimal Medical Treatment Under-used in Vascular Peripheral Disease

Diabetes and Peripheral Vascular Disease: Old Drugs, New Evidence

Drug-Coated Balloons in Critical Ischemia: The Paradigm of Randomized Evidence vs. Logbooks

Last News

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access